Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data
- 23 April 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 167 (3) , 489-499
Abstract
Purpose Glioblastoma is a malignant brain tumor with a poor prognosis. Genetic mutations associated with this disease are complex are not fully understood and require further elucidation for the development of new treatments. The purpose of this study was to comprehensively analyze genetic mutations in glioblastomas and evaluate the usefulness of RNA sequencing. Patients and methods We analyzed 42 glioblastoma specimens that were resected in routine clinical practice and found wild-type variants of the IDH1 and IDH2 genes. RNA was extracted from frozen specimens and sequenced, and genetic analyses were performed using the CLC Genomics Workbench. Results The most common genetic alterations in the 42 glioblastoma specimens were TP53 mutation (28.6%), EGFR splicing variant (16.7%), EGFR mutation (9.5%), and FGFR3 fusion (9.5%). Novel genetic mutations were detected in 8 patients (19%). In 12 cases (28.6%), driver gene mutations were not detected, suggesting an association with PPP1R14A overexpression. Our findings suggest the transcription factors SOX10 and NKX6-2 are potential markers in glioblastoma. Conclusion RNA sequencing is a promising approach for genotyping glioblastomas because it provides comprehensive information on gene expression and is relatively cost-effective.Keywords
This publication has 31 references indexed in Scilit:
- Metagenome analysis using the Kraken software suiteNature Protocols, 2022
- Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtypeNature Communications, 2020
- Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaActa Neuropathologica, 2018
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- From Promiscuity to Precision: Protein Phosphatases Get a MakeoverMolecular Cell, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The type III epidermal growth factor receptor mutationAnnals of Oncology, 2001
- Diffuse brain stem tumor in an adolescent with multiple enchondromatosis (Ollier's disease)Child's Nervous System, 1999